Journal
ADVANCED DRUG DELIVERY REVIEWS
Volume 161, Issue -, Pages 110-123Publisher
ELSEVIER
DOI: 10.1016/j.addr.2020.08.006
Keywords
Exosomes; GPI-anchored proteins; Biomarkers; Cancer; ExoScreen; Nano-plasmonic sensor; ExoView
Categories
Funding
- CNRS
- University of Montpellier
Ask authors/readers for more resources
Exosomes are 50-100 nm membranous vesicles actively released by cells which can be indicative of a diseased cell status. They contain various kinds of molecule - proteins, mRNA, miRNA, lipids - that are actively being studied as potential biomarkers. Hereafter I put forward several arguments in favor of the potential use of glycosylphosphatidylinositol-anchored proteins (GPI-APs) as biomarkers especially of cancerous diseases. I will briefly update readers on the exosome field and review various features of GPI-APs, before further discussing the advantages of this class of proteins as potential exosomal biomarkers. I will finish with a few examples of exosomal GPI-APs that have already been demonstrated to be good prognostic markers, as well as innovative approaches developed to quantify these exosomal biomarkers. (C) 2020 Elsevier B.V. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available